Low-Dose CT - Stage I Testicular Cancer

Status Active, not recruiting

Clinical Trial Summary

Patients with primary germ cell cancer of the testicles confined to the testis can avoid adjuvant treatment by entering a surveillance protocol. In the surveillance protocol, patients are followed for up to ten years with serial computed tomography scans to detect recurrence. Multiple CT scans expose patients to a significant amount of radiation, which may be associated with an increased risk of secondary malignancies. This study hypothesizes that low dose CT scans are as effective as standard dose CT scans in detecting disease recurrence in this setting and will significantly reduce radiation exposure in this group of patients.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03142802
Study type	Interventional
Source	University Health Network, Toronto
Contact
Status	Active, not recruiting
Phase	N/A
Start date	September 16, 2005
Completion date	September 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT00772694` - Sorafenib Monotherapy in Inoperable/Recurrent Germ Cell Carcinoma Refractory to Chemotherapy	Phase 2
Completed	`NCT00705094` - Cardiac Function and Cardiovascular Risk Profile in Testicular Cancer Patients	N/A
Terminated	`NCT00531687` - Trial of Paclitaxel, Gemcitabine and Cisplatin in Patients With Relapsing Germ Cell Cancer	Phase 2
Terminated	`NCT00820287` - Identification of Predictive Markers for Testis Cancer in a Population of Men With High Risk	N/A
Completed	`NCT00216801` - Relationship of Ochratoxin A to Upper Urologic Cancers	N/A
Recruiting	`NCT03232541` - The Effects of Acupuncture and the Therapist´s Communication on Chemotherapy Induced Nausea and Vomiting	N/A
Completed	`NCT03557177` - Clinical Characterisation of the Vascular Effects of Cis-platinum Based Chemotherapy in Patients With Testicular Cancer
Active, not recruiting	`NCT01783145` - Shared Care Follow-up After Chemotherapy for Testicular Cancer
Recruiting	`NCT05611307` - Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
Completed	`NCT02573584` - Vascular Fingerprint Validation Study
Recruiting	`NCT05670938` - Follow-up After Surgery for Testicular Cancer
Recruiting	`NCT02994758` - Development of Diagnostics and Treatment of Urological Cancers	N/A
Completed	`NCT02991209` - Study of Testosterone vs Placebo in Testicular Cancer Survivors	Phase 2/Phase 3
Completed	`NCT02602041` - Knowledge and Attitudes Regarding Healthy Lifestyle and Health Behavior Change in Cancer Patients and Their Partners; A Pilot Study
Completed	`NCT02092740` - REtrospective Study of TESTIcular CAncer Patients at the University Magdeburg	N/A
Completed	`NCT01482741` - Understanding Patient Perspectives on the Risks of Ionizing Radiation Used for Medical Imaging	N/A
Active, not recruiting	`NCT01242072` - Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies	Phase 1
Completed	`NCT01242631` - Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer	Phase 2
Completed	`NCT01135849` - B-Receptor Signaling in Cardiomyopathy	N/A
Completed	`NCT00183820` - Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma	Phase 2